Article in Diagnostics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors.
Ozlem CandanDivision of Hematology, Department of Internal Medicine, Marmara University School of Medicine, Pendik Training and Research Hospital, 34899 Istanbul, Turkey.ORCID 0009-0000-4288-6370
Arda BayarDivision of Hematology, Department of Internal Medicine, Marmara University School of Medicine, Pendik Training and Research Hospital, 34899 Istanbul, Turkey.ORCID 0000-0002-4586-3809
Narmin NaghizadaDepartment of Internal Medicine, Marmara University School of Medicine, Pendik Training and Research Hospital, 34899 Istanbul, Turkey.
Derya DemirtasDivision of Hematology, Department of Internal Medicine, Marmara University School of Medicine, Pendik Training and Research Hospital, 34899 Istanbul, Turkey.ORCID 0000-0001-9449-8759
Ahmet Mert YanikDivision of Hematology, Department of Internal Medicine, Marmara University School of Medicine, Pendik Training and Research Hospital, 34899 Istanbul, Turkey.ORCID 0000-0002-1908-0149
Asu Fergun YilmazDivision of Hematology, Department of Internal Medicine, Marmara University School of Medicine, Pendik Training and Research Hospital, 34899 Istanbul, Turkey.
Ayse Tulin TuglularDivision of Hematology, Department of Internal Medicine, Marmara University School of Medicine, Pendik Training and Research Hospital, 34899 Istanbul, Turkey.
Tayfur ToptasDivision of Hematology, Department of Internal Medicine, Marmara University School of Medicine, Pendik Training and Research Hospital, 34899 Istanbul, Turkey.ORCID 0000-0002-2690-8581
Isik AtagunduzDivision of Hematology, Department of Internal Medicine, Marmara University School of Medicine, Pendik Training and Research Hospital, 34899 Istanbul, Turkey.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Determinants of Eligibility and Timing of Autologous Transplantation in Multiple Myeloma: The Role of R-MCI and Diagnostic Plasma Cell Burden. · full record | OpenQuestion